Antiviral Drug

Shanghai, China, August 14, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced that the U.S. Food and Drug Administration...

Miami, Florida, August 12, 2026 Summit Therapeutics announced that its partner Akeso Inc. received marketing authorization from China’s National...

Shanghai, China, August 12, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced that China’s National Medical Products Administration (NMPA)...

SHANGHAI, April 10, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. has announced a key clinical milestone with the successful dosing...

SHELTON, Connecticut, United States, April 7, 2026 NanoViricides, Inc., a clinical-stage biopharmaceutical company, announced that it has filed an...